
Agios Pharmaceuticals, Inc.
UnclaimedPharmaceutical Preparation ManufacturingCambridge, MA
Founded
2007
Primary NAICS
325412
CAGE code
86WZ9
Federal awards
$73.1K
Overview
Over the 12+ years Agios has been in existence, we have remained committed to patients first and to following the science. Our legacy is rooted in a powerful set of strengths, values and competencies. We have built on our core differentiators to make a positive difference for patients through truly differentiated therapies. This foundation will remain constant at Agios and accelerate our impact moving forward.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $73,080 | 7 |
| 2025 | Department of Veterans Affairs | $0 | 4 |
| 2024 | Department of Veterans Affairs | $0 | 2 |
| 2023 | Department of Veterans Affairs | $0 | 3 |
| 2022 | Department of Veterans Affairs | $0 | 5 |